{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:53:40Z","timestamp":1790970820514,"version":"4.1.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,2]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Angioimmunoblastic T-cell lymphoma (AITL), classified as nodal T-follicular helper cell lymphoma, angioimmunoblastic type, is an aggressive lymphoma frequently complicated by immune dysregulation. Owing to overlapping histopathological features, particularly Hodgkin\/Reed\u2013Sternberg\u2013like cells, AITL may be initially misdiagnosed as Hodgkin lymphoma, leading to delayed recognition and inappropriate management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 72-year-old man presented with progressive fatigue, recurrent fever, severe pancytopenia, and splenomegaly after an outside diagnosis of Hodgkin lymphoma based on inguinal lymph node biopsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Laboratory findings revealed hypertriglyceridemia and marked hyperferritinemia, consistent with secondary hemophagocytic lymphohistiocytosis (HLH). Reevaluation of archived lymph node tissue demonstrated Epstein\u2013Barr virus\u2013encoded RNA positivity, T-cell receptor gene rearrangement, and an immunophenotype diagnostic of nodal T-follicular helper cell lymphoma, angioimmunoblastic type with scattered Hodgkin\/Reed\u2013Sternberg\u2013like cells. Plasma Epstein\u2013Barr virus DNA was detected at low levels. The disease was staged as Lugano stage III with B symptoms and classified as high risk by the International Prognostic Index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>HLH-directed therapy with etoposide and dexamethasone was initiated for rapid disease control, followed by cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy for lymphoma treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Partial remission was achieved after 6 cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. The patient later experienced disease progression with clinically suspected recurrent HLH despite salvage therapy and died on March 29, 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case underscores the diagnostic pitfalls of AITL complicated by HLH and highlights the importance of early pathological reassessment and a stepwise treatment approach prioritizing control of hyperinflammation in patients with discordant clinical and pathological findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050979","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:01:02Z","timestamp":1790967662000},"page":"e50979","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Angioimmunoblastic T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis initially misdiagnosed as classical Hodgkin lymphoma"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4964-2289","authenticated-orcid":false,"given":"Rui","family":"Li","sequence":"first","affiliation":[{"name":"Department of Oncology, The People\u2019s Hospital of Rongchang District, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, The People\u2019s Hospital of Rongchang District, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The People\u2019s Hospital of Rongchang District, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The People\u2019s Hospital of Rongchang District, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nengping","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The People\u2019s Hospital of Rongchang District, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Oncology, The People\u2019s Hospital of Rongchang District, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3092-0905","authenticated-orcid":false,"given":"Yue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The People\u2019s Hospital of Rongchang District, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1007\/s10238-023-01197-9","article-title":"Advances in the pathogenesis and therapeutic strategies of angioimmunoblastic T-cell lymphoma.","volume":"23","author":"Zhang","year":"2023","journal-title":"Clin Exp Med"},{"key":"R2-20261002","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.3390\/curroncol28060456","article-title":"Recent advances in diagnosis and therapy of angioimmunoblastic T cell lymphoma.","volume":"28","author":"Mohammed Saleh","year":"2021","journal-title":"Curr Oncol"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood-2016-09-692541","article-title":"Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.","volume":"129","author":"Lunning","year":"2017","journal-title":"Blood"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic lymphohistiocytosis.","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"101515","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy.","volume":"34","author":"Griffin","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R6-20261002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41375-024-02135-8","article-title":"Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis.","volume":"38","author":"Knauft","year":"2024","journal-title":"Leukemia"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/annonc\/mdv237","article-title":"Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.","volume":"26","author":"Shi","year":"2015","journal-title":"Ann Oncol"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"105696","DOI":"10.1016\/j.humpath.2024.105696","article-title":"Angioimmunoblastic T-cell lymphoma: current diagnostic insights and advances.","volume":"156","author":"Matsumoto","year":"2025","journal-title":"Hum Pathol"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/aqab090","article-title":"How I diagnose angioimmunoblastic T-cell lymphoma.","volume":"156","author":"Xie","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/16078454.2022.2113600","article-title":"Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center.","volume":"27","author":"Li","year":"2022","journal-title":"Hematology"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/JBM.S46255","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management.","volume":"5","author":"George","year":"2014","journal-title":"J Blood Med"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00277-007-0278-6","article-title":"Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome.","volume":"86","author":"Han","year":"2007","journal-title":"Ann Hematol"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF02982065","article-title":"A clinicopathological study of 20 patients with T\/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK\/T-cell lymphoma.","volume":"74","author":"Takahashi","year":"2001","journal-title":"Int J Hematol"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1111\/jcmm.17543","article-title":"A retrospective analysis of EBV-DNA status with the prognosis of lymphoma.","volume":"26","author":"Qiu","year":"2022","journal-title":"J Cell Mol Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:01:04Z","timestamp":1790967664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050979"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":15,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050979","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"2026-01-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}